Innovent Biologics (suzhou) Co. Ltd.

This early-stage study tested the safety and how the body processes a new weight-loss medication called IBI362 in Chinese teenagers with obesity. Thirty-six adolescents who hadn't lost much weight through diet and exercise alone received either the drug or a placebo. Researchers …

This clinical trial tested a new oral drug called GFH925 for people with advanced solid tumors that have a specific genetic change called KRAS G12C. The study aimed to find a safe dose and see if the drug could shrink tumors in cancers like non-small cell lung cancer and colorect…

This study tested an investigational drug called IBI112 for people with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. About 150 participants received either the drug or a placebo to see if it could help achieve and maintain clinical remission over a…

This study tested whether an experimental drug called IBI311 could safely reduce eye bulging and inflammation in people with thyroid eye disease. Thirty-eight adults with either active or inactive forms of the condition received different doses of the drug or a comparison. Resear…

This study tested an experimental weekly injection called IBI362 to see if it helps people lose weight. It involved 328 overweight or obese adults in China who also followed a diet and exercise plan. Researchers compared several doses of the drug against a placebo (a dummy treatm…

This early-stage study tested the safety of a new asthma drug called IBI3002 in healthy volunteers and people with mild to moderate asthma. Researchers gave single doses to 52 participants to check for side effects and see how the drug moves through the body. The main goal was to…

This early-stage study tested a new drug called IBI334 in adults with advanced solid tumors that could not be removed by surgery. The main goals were to check the drug's safety, see how much patients could tolerate, and gather initial signs of whether it could shrink or control t…

This completed Phase 3 study tested whether a new combination of two immunotherapy drugs (IBI310 and sintilimab) works better than the standard drug sorafenib for people with advanced liver cancer that cannot be removed by surgery. The trial involved 344 patients who had not rece…

This early-stage study tested a new drug called IBI355 in 30 adults with primary Sjogren's syndrome, an autoimmune disease that causes dry eyes and mouth. The main goal was to check how safe the drug is and how the body processes it when given in increasing doses. Researchers als…

This early-stage study tested the safety and how the body processes a new drug called IBI356 for atopic dermatitis (eczema). Researchers gave the drug to 99 healthy volunteers and people with moderate-to-severe eczema to check for side effects and measure drug levels in the blood…

This was an early-stage study to test a new cancer drug called IBI133 for the first time in people. It involved 19 adults with advanced solid tumors that could not be removed by surgery and had stopped responding to standard treatments. The main goals were to find a safe dose and…

This early-stage study tested a new cancer drug called IBI129 in people with advanced solid tumors that cannot be removed by surgery. The main goals were to find a safe and effective dose and to see how the body processes the drug. About 180 adults with various types of advanced …